Crossmark

Efficacy and Safety of KarXT (Xanomeline-Trospium; Cobenfy™) in Schizophrenia: A Systematic and Meta-Analysis Review of Randomized Controlled Trials

Crossref DOI link: https://doi.org/10.1007/s11126-025-10226-7

Published Online: 2025-10-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Azargoonjahromi, Ali https://orcid.org/0000-0002-6997-9419
Nasiri, Hamide https://orcid.org/0009-0002-2853-2298
License Information

Text and Data Mining valid from 2025-10-04

Version of Record valid from 2025-10-04
More Information

Article History

Received: 27 August 2025

Accepted: 23 September 2025

First Online: 4 October 2025

Declarations

:

: There are no conflicting interests to be stated.